OvaScience (OVAS) Bullish Stance Reiterated at Leerink Partners Post Q4

Go back to OvaScience (OVAS) Bullish Stance Reiterated at Leerink Partners Post Q4

Ovascience (OVAS) Misses Q4 EPS by 20c

March 16, 2015 4:34 PM EDT

Ovascience (NASDAQ: OVAS) reported Q4 EPS of ($0.79), $0.20 worse than the analyst estimate of ($0.59).

For earnings history and earnings-related data on Ovascience (OVAS) click here.

... More